GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders.
GliaPharm has raised €1.9M across 1 funding round, most recently a Seed round in May 2020. Based in Geneva, Switzerland; founded 2016; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-05-26 | Seed | €1.9M |
| — |
| View deal → |
